Test bank for Tietz Fundamentals of Clinical Chemistry
and Molecular Diagnostics,
8th Edition by Nader Rifai, PhD
Chapters 1 - 49
,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 8th Edition Test Bank
Table of contents:
I. Principles Of Laboratory Medicine
Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
Chapter 3. Clinical Evaluation of Methods
Chapter 4. Evidence-Based Laboratory Medicine
Chapter 5. Establishment and Use of Reference Values
Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
Chapter 7. Quality Management
II. Analytical Techniques And Instrumentation
Chapter 8. Principles of Basic Techniques and Laboratory Safety
Chapter 9. Optical Techniques
Chapter 10. Electrochemistry and Chemical Sensors
Chapter 11. Electrophoresis
Chapter 12. Chromatography
Chapter 13. Mass Spectrometry
Chapter 14. Enzyme and Rate Analyses
Chapter 15. Immunochemical Techniques
Chapter 16 Automation
Chapter 17. Point-of-Care Instrumentation
III. Analytes
Chapter 18. Amino Acids, Peptides, and Proteins
Chapter 19. Serum Enzymes
Chapter 20. Tumor Markers and Cancer Genes
Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
Chapter 22. Carbohydrates
Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
Chapter 24. Electrolytes and Blood Gases
Chapter 25. Hormones
Chapter 26. Catecholamines and Serotonin
Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
Chapter 28. Hemoglobin, Iron, and Bilirubin
Chapter 29. Porphyrins and Porphyrias
Chapter 30. Therapeutic Drugs and Their Management
Chapter 31. Clinical Toxicology
Chapter 32. Toxic Metals
IV. Pathophysiology
Chapter 33. Diabetes
,Chapter 34. Cardiovascular Disease
Chapter 35. Kidney Disease
Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
Chapter 37. Liver Disease
Chapter 38. Gastrointestinal and Pancreatic Diseases
Chapter 39. Disorders of Bone and Mineral Metabolism
Chapter 40. Disorders of the Pituitary Gland
Chapter 41. Disorders of the Adrenal Cortex
Chapter 42. Thyroid Disorders
Chapter 43. Reproduction-Related Disorders
Chapter 44. Pregnancy and Prenatal Testing
Chapter 45. Newborn Screening and Inborn Errors of Metabolism
Chapter 46. Pharmacogenetics
V. Molecular Diagnostics
Chapter 47. Principles of Molecular Biology
Chapter 48. Nucleic Acid Techniques and Applications
Chapter 49. Genomes and Nucleic Acid Alterations
, Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine Test
Bank
MULTIPLE CHOICE
1. An individual working in a clinical chemistry laboratory is married to a sales representative
who works for a company that sells chemistry laboratory supplies. When the laboratory
manager requests a list of needed supplies, cost of supplies, and vendors, this individual
onlyrecommends the spouse’s company as the vendor. This is considered to be a(n):
a. accounting issue.
b. possible conflict of interest.
c. maintenance of confidentiality issue.
d. problem with resource allocation.
ANS: B
Concern has been raised over the interrelationships between practitioners in the medical
fieldand commercial suppliers of drugs, devices, equipment, etc., to the medical profession.
Similarly, relationships have been scrutinized between clinical laboratorians and
manufacturers and providers of diagnostic equipment and supplies. These concerns led the
National Institutes of Health (NIH) in 1995 to require official institutional review of financial
disclosure by researchers and management of situations in which disclosure indicates
potentialconflicts of interest.
DIF: 1 REF: Page 4-5 OBJ: 6 | 7
2. A tpatient tvisits ther tphysician tstating tthat ther tprescribed tpainkiller tis tnot tworking tto
treduce tthe tpain tfollowing ther trecent tsurgery. tA tfriend tof tthe tpatient tclaims tthat tthe
tsame tpainkillert“worked twonders” tto treduce ther tpain tafter tthe tsame tsurgery. tThe
tphysician tstates tthat tthe tdifference tin tthe teffect tof tthe tdrug tmight tbe tcaused tby ,
twhich tis tstudied tin tpharmacogenetics.
a. epidemiology
b. an tinherited tdisease
c. a tconflict tof tinterest
d. a tgenetic tvariation tin tdrug-metabolizing tenzymes
ANS: t D
Pharmacogenetics tis tthe tstudy tof tthe tgenetic tvariation tof tdrug tmetabolism
tbetweentindividuals.
DIF: 1 REF: t t tPage t3 OBJ: t 1
3. John tworks tin ta tmolecular tdiagnostics tlaboratory tand treceives ta tblood tsample tthat
thas tthe tname tof ta tclose tfriend tprinted ton tthe tbar-coded tlabel. tThe tgenetic ttest tthat
tis tordered ton tthetfriend’s tsample twould tprovide tdiagnostic tinformation tabout ta
tdisorder tthat thas ta tpoor tprognosis, tand tthe ttest tis tusually tperformed tby tJohn. tHe
tasks ta tfellow temployee tto tanalyzetthe tsample tfor thim tand tnot tdivulge tthe tresults.
tThis tethical tissue tconcerns:
a. confidentiality tof tpatient tgenetic tand tmedical tinformation.
b. a tconflict tof tinterest.
c. resource tallocation.
d. diagnostic taccuracy.
and Molecular Diagnostics,
8th Edition by Nader Rifai, PhD
Chapters 1 - 49
,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 8th Edition Test Bank
Table of contents:
I. Principles Of Laboratory Medicine
Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
Chapter 3. Clinical Evaluation of Methods
Chapter 4. Evidence-Based Laboratory Medicine
Chapter 5. Establishment and Use of Reference Values
Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
Chapter 7. Quality Management
II. Analytical Techniques And Instrumentation
Chapter 8. Principles of Basic Techniques and Laboratory Safety
Chapter 9. Optical Techniques
Chapter 10. Electrochemistry and Chemical Sensors
Chapter 11. Electrophoresis
Chapter 12. Chromatography
Chapter 13. Mass Spectrometry
Chapter 14. Enzyme and Rate Analyses
Chapter 15. Immunochemical Techniques
Chapter 16 Automation
Chapter 17. Point-of-Care Instrumentation
III. Analytes
Chapter 18. Amino Acids, Peptides, and Proteins
Chapter 19. Serum Enzymes
Chapter 20. Tumor Markers and Cancer Genes
Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
Chapter 22. Carbohydrates
Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
Chapter 24. Electrolytes and Blood Gases
Chapter 25. Hormones
Chapter 26. Catecholamines and Serotonin
Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
Chapter 28. Hemoglobin, Iron, and Bilirubin
Chapter 29. Porphyrins and Porphyrias
Chapter 30. Therapeutic Drugs and Their Management
Chapter 31. Clinical Toxicology
Chapter 32. Toxic Metals
IV. Pathophysiology
Chapter 33. Diabetes
,Chapter 34. Cardiovascular Disease
Chapter 35. Kidney Disease
Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
Chapter 37. Liver Disease
Chapter 38. Gastrointestinal and Pancreatic Diseases
Chapter 39. Disorders of Bone and Mineral Metabolism
Chapter 40. Disorders of the Pituitary Gland
Chapter 41. Disorders of the Adrenal Cortex
Chapter 42. Thyroid Disorders
Chapter 43. Reproduction-Related Disorders
Chapter 44. Pregnancy and Prenatal Testing
Chapter 45. Newborn Screening and Inborn Errors of Metabolism
Chapter 46. Pharmacogenetics
V. Molecular Diagnostics
Chapter 47. Principles of Molecular Biology
Chapter 48. Nucleic Acid Techniques and Applications
Chapter 49. Genomes and Nucleic Acid Alterations
, Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine Test
Bank
MULTIPLE CHOICE
1. An individual working in a clinical chemistry laboratory is married to a sales representative
who works for a company that sells chemistry laboratory supplies. When the laboratory
manager requests a list of needed supplies, cost of supplies, and vendors, this individual
onlyrecommends the spouse’s company as the vendor. This is considered to be a(n):
a. accounting issue.
b. possible conflict of interest.
c. maintenance of confidentiality issue.
d. problem with resource allocation.
ANS: B
Concern has been raised over the interrelationships between practitioners in the medical
fieldand commercial suppliers of drugs, devices, equipment, etc., to the medical profession.
Similarly, relationships have been scrutinized between clinical laboratorians and
manufacturers and providers of diagnostic equipment and supplies. These concerns led the
National Institutes of Health (NIH) in 1995 to require official institutional review of financial
disclosure by researchers and management of situations in which disclosure indicates
potentialconflicts of interest.
DIF: 1 REF: Page 4-5 OBJ: 6 | 7
2. A tpatient tvisits ther tphysician tstating tthat ther tprescribed tpainkiller tis tnot tworking tto
treduce tthe tpain tfollowing ther trecent tsurgery. tA tfriend tof tthe tpatient tclaims tthat tthe
tsame tpainkillert“worked twonders” tto treduce ther tpain tafter tthe tsame tsurgery. tThe
tphysician tstates tthat tthe tdifference tin tthe teffect tof tthe tdrug tmight tbe tcaused tby ,
twhich tis tstudied tin tpharmacogenetics.
a. epidemiology
b. an tinherited tdisease
c. a tconflict tof tinterest
d. a tgenetic tvariation tin tdrug-metabolizing tenzymes
ANS: t D
Pharmacogenetics tis tthe tstudy tof tthe tgenetic tvariation tof tdrug tmetabolism
tbetweentindividuals.
DIF: 1 REF: t t tPage t3 OBJ: t 1
3. John tworks tin ta tmolecular tdiagnostics tlaboratory tand treceives ta tblood tsample tthat
thas tthe tname tof ta tclose tfriend tprinted ton tthe tbar-coded tlabel. tThe tgenetic ttest tthat
tis tordered ton tthetfriend’s tsample twould tprovide tdiagnostic tinformation tabout ta
tdisorder tthat thas ta tpoor tprognosis, tand tthe ttest tis tusually tperformed tby tJohn. tHe
tasks ta tfellow temployee tto tanalyzetthe tsample tfor thim tand tnot tdivulge tthe tresults.
tThis tethical tissue tconcerns:
a. confidentiality tof tpatient tgenetic tand tmedical tinformation.
b. a tconflict tof tinterest.
c. resource tallocation.
d. diagnostic taccuracy.
